推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33363733,021-34612310

chinasupport@letpub.com

登录 注册 新注册优惠

Journal of Breast Cancer

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 J BREAST CANCER最新评论:各位前辈,小弟刚投了忘记写cover letter了, 3天了稿件一直处于manuscript submitted状态,没有给稿件号,manuscript number处是... (2022-10-04)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Journal of Breast Cancer期刊基本信息Hello,您是该期刊的第21455位访客


基本信息 登录收藏
期刊名字Journal of Breast CancerJournal of Breast Cancer

J BREAST CANCER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.1
50人评分
我要评分

声誉
7.6

影响力
4.8

速度
7.0

期刊ISSN1738-6756
微信扫码收藏此期刊
2023-2024最新影响因子
(数据来源于搜索引擎)
2.2 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:2.146
2023-2024自引率4.50%点击查看自引率趋势图
五年影响因子2.2
JCI期刊引文指标 0.46
h-index 29
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
3.800.6710.663
学科分区排名百分位
大类:Medicine
小类:Oncology
Q3215 / 404
大类:Medicine
小类:Cancer Research
Q3159 / 230

期刊简介
The Journal of Breast Cancer (abbreviated as 'J Breast Cancer') is the official journal of the Korean Breast Cancer Society, which is issued quarterly in the last day of March, June, September, and December each year since 1998. All the contents of the Journal is available online at the official journal website (http://ejbc.kr) under open access policy. The journal aims to provide a forum for the academic communication between medical doctors, basic science researchers, and health care professionals to be interested in breast cancer. To get this aim, we publish original investigations, review articles, brief communications including case reports, editorial opinions on the topics of importance to breast cancer, and welcome new research findings and epidemiological studies, especially when they contain a regional data to grab the international reader's interest. Although the journal is mainly dealing with the issues of breast cancer, rare cases among benign breast diseases or evidence-based scientifically written articles providing useful information for clinical practice can be published as well.
期刊官方网站http://ejbc.kr/
期刊投稿网址https://www.editorialmanager.com/JBREASTCANCER
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Journal of Breast Cancer的语言要求,还能让Journal of Breast Cancer编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Journal of Breast Cancer编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式KOREAN BREAST CANCER SOC, 163 SINMUNRO 1-GA JONGRO-GU, OFFICE BUILDING SUITE 2024, SEOUL, SOUTH KOREA, 110-999
出版商Korean Breast Cancer Society
涉及的研究方向医学-肿瘤学
出版国家或地区SOUTH KOREA
出版语言English, Korean
出版周期Quarterly
出版年份2003
年文章数 43点击查看年文章数趋势图
Gold OA文章占比99.28%
研究类文章占比:
文章 ÷(文章 + 综述)
86.05%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ3209/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ3220/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区4区3区
ONCOLOGY
肿瘤学
3区1区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 4区4区3区
ONCOLOGY
肿瘤学
3区3区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区1区
ONCOLOGY
肿瘤学
3区2区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1738-6756%5BISSN%5D
平均审稿速度网友分享经验:
较慢,6-12周
平均录用比例网友分享经验:
容易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Journal of Breast Cancer顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Journal of Breast Cancer期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Journal of Breast Cancer中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Journal of Breast Cancer上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    Nature Reviews Clinical Oncology12799.40
    NATURE REVIEWS CANCER396111.90
    ANNALS OF ONCOLOGY21063.90
    CANCER CELL29555.20
    JOURNAL OF CLINICAL ONCOLOGY49441.20
    LANCET ONCOLOGY27462.10
    CANCER RESEARCH41116.10
    SEMINARS IN CANCER BIOLOGY13426.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6718.20
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE659643
    BIOMATERIALS555107
    BIOMEDICINE & PHARMACOTHERAPY533123
    Frontiers in Pharmacology501092
    Journal of Materials Chemistry B492609
    Frontiers in Immunology476925
    COMPUTERS IN BIOLOGY AND MEDICINE453535
    JOURNAL OF ETHNOPHARMACOLOGY451889
    COLLOIDS AND SURFACES B-BIOINTERFACES430861
    Frontiers in Oncology424936
  •  

    Journal of Breast Cancer Journal of Breast Cancer
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Pokemon Inhibits Transforming Growth Factor β-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1.

    Author: Chen L1, Zhong J1, Liu JH1, Liao DF2, Shen YY1, Zhong XL1, Xiao X1, Ding WJ1, Peng XD1, Xiong W3, Zu XY1.
    Journal: J Breast Cancer. 2019 Feb 15;22(1):15-28. doi: 10.4048/jbc.2019.22.e11. eCollection 2019 Mar.
        PubMed      DOI
    2.Screening of Recurrence Related MicroRNA in Ductal Carcinoma In Situ and Functional Study of MicroRNA-654-5p.

    Author: Li S1, Pu T2,3, Xiao L3, Gao H3,4, Li L3,4, Ye F3,4, Liu Y1, Bu H2,3,4.
    Journal: J Breast Cancer. 2019 Jan 2;22(1):52-66. doi: 10.4048/jbc.2019.22.e4. eCollection 2019 Mar.
        PubMed      DOI
    3.Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death.

    Author: Fu J1, Zhong C2,3, Wu L4,5, Li D2,3, Xu T6, Jiang T7, Yang J8, Du J9.
    Journal: J Breast Cancer. 2019 Mar 11;22(1):96-108. doi: 10.4048/jbc.2019.22.e13. eCollection 2019 Mar.
        PubMed      DOI
    4.Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study.

    Author: Li X1,2, Yang M2, Zhang Q3, Fan Y3, Zhu T2, Chen F2, Wang K1,2.
    Journal: J Breast Cancer. 2019 Feb 2;22(1):131-140. doi: 10.4048/jbc.2019.22.e10. eCollection 2019 Mar.
        PubMed      DOI
    5.Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide.

    Author: Ro J, Cheng FT, Sriuranpong V, Villalon A, Smruti BK, Tsang J, Yap YS; Asian Working Group for Eribulin Clinical Guide.
    Journal: J Breast Cancer. 2016 Mar;19(1):8-17. doi: 10.4048/jbc.2016.19.1.8. Epub 2016 Mar 25. Review.
        PubMed  
    6.Prolactin Inhibits BCL6 Expression in Breast Cancer Cells through a MicroRNA-339-5p-Dependent Pathway.

    Author: Yan H, Zhao M, Huang S, Chen P, Wu WY, Huang J, Wu ZS, Wu Q.
    Journal: J Breast Cancer. 2016 Mar;19(1):26-33. doi: 10.4048/jbc.2016.19.1.26. Epub 2016 Mar 25.
        PubMed  
    7.Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer.

    Author: Wang J, Shan M, Liu T, Shi Q, Zhong Z, Wei W, Pang D.
    Journal: J Breast Cancer. 2016 Mar;19(1):61-7. doi: 10.4048/jbc.2016.19.1.61. Epub 2016 Mar 25.
        PubMed  
    8.Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy.

    Author: Wen G, Zhang JS, Zhang YJ, Zhu YJ, Huang XB, Guan XX.
    Journal: J Breast Cancer. 2016 Jun;19(2):176-84. doi: 10.4048/jbc.2016.19.2.176. Epub 2016 Jun 24.
        PubMed  
    9.An unusual case of gastric cancer presenting with breast metastasis with pleomorphic microcalcifications.

    Author: Luk YS, Ka SY, Lo SS, Chu CY, Ma MW.
    Journal: J Breast Cancer. 2012 Sep;15(3):356-8. doi: 10.4048/jbc.2012.15.3.356. Epub 2012 Sep 28.
        PubMed  
    10.Effect of bFGF on the MCF-7 Cell Cycle with CD44(+)/CD24(-): Promoting the G0/G1→G2/S Transition.

    Author: Yang ZL, Cheng K, Han ZD.
    Journal: J Breast Cancer. 2012 Dec;15(4):388-92. doi: 10.4048/jbc.2012.15.4.388. Epub 2012 Dec 31.
        PubMed  
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Energy Material Advances013.80
    Journal of High Energy Astrophysics119.70
    VIEW012.60
    HARVARD BUSINESS REVIEW01.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.90
    ACM Transactions on Intelligent Systems and Technology469.30
    Journal of the American Nutrition Association02.50
    TRANSACTIONS OF TIANJIN UNIVERSITY012.50
    Machine Intelligence Research06.70
    Molecular Biomedicine06.30
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共27


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室